Apart from IT, marine economy, health industries and aviation/aerospace, Shenzen’s life science industry grows significantly faster than the national GDP, partly due to BGI and Beike Cell Technologies. Shenzen plans to extend these pillars of growth further and become...
Dongxing Securities assumes that the Chinese market fo therapeutic antibodies can grow 10fold as soon as Chinese companies have acquired mature industrial antibody know-how including R&D, HTS, production technology and quality control. China Bio news release...
After analysis and immunofluorescence double staining, spermatogonial stem cell marker gene expression remained unchanged. In vitro experimental results showed that after the long-term culture of cynomolgus monkey stem cells their physiological function remained....
Researchers at Taipei’s Veterans General Hospital report that Parp1 regulates nuclear reprogramming and promotes iPSC generation with reduced risk of carcinogenic side effects China Bio news release, October 6, 2013
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
